When there is a pandemic there is no time to waste: should we have hydroxychloroquine in our armoury against COVID-19 infected patients?

The current use of chloroquine and/or hydroxychloroquine, a drug currently used to treat autoimmune rheumatic diseases, in treating severe acute respiratory syndrome caused by coronavirus 2 (SARSCoV-2) or COVID-19-infected patients with pneumonia is a matter of intense consideration. We wish to ente...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Mediterr J Rheumatol
Prif Awduron: Bogdanos, Dimitrios P., Daniil, Zoi, Zakynthinos, Epaminondas, Gourgoulianis, Konstantinos, Sakkas, Lazaros I.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: The Mediterranean Journal of Rheumatology (MJR) 2020
Pynciau:
Viewpoint
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7219635/
https://ncbi.nlm.nih.gov/pubmed/32411941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31138/mjr.31.1.94
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg